The New Client Profile Most Coaches Are Underestimating
The 2026 personal training industry report identifies GLP-1 medications as one of the most transformative forces in the profession. Semaglutide, tirzepatide, and their equivalents have created millions of people in rapid weight loss, often without structured fitness support.
The clinical problem: up to 30 to 40% of weight lost on GLP-1 therapy can come from lean muscle mass. These clients aren't just losing fat. They're losing muscle, which degrades their basal metabolic rate, weakens their skeletal structure, and over time can create serious health problems. These people need coaching, but not traditional cardio-focused weight loss coaching. They need muscle-preservation programming, protein-forward nutrition support, and someone who understands how medication side effects affect energy and training capacity.
Why This Is a Real Business Opportunity
The socioeconomic profile of GLP-1 clients is specific. These medications cost between $800 and $1,200 per month in most markets and often aren't fully covered by insurance. People on semaglutide or tirzepatide are typically higher-income individuals who already invest heavily in their health.
These clients understand value. They pay for measurable results. And when they find a coach who understands their medical context and can adapt their program accordingly, they value that expertise and accept premium pricing. Coaches who've started positioning in this segment report higher-than-average retention rates. These clients come with a specific medical goal, and if the coach helps them achieve it, loyalty is strong.
What the Positioning Actually Requires
Positioning as a GLP-1 specialist doesn't require medical credentials, but it does require solid knowledge: basic GLP-1 pharmacology, muscle-preservation programming (heavy compound movements, anabolic stimulus even in caloric deficit, volume management around fluctuating energy levels), and protein-forward nutrition support around reduced appetite.
The Window Is Closing
In 2026, most coaches aren't trained on GLP-1 medications. Those who invest now in this expertise, who develop real client experience and start communicating around this specialty, have a positioning advantage that won't last indefinitely. In two or three years, GLP-1 client certifications will be standard. Coaches with actual field experience will have a lead that newer-certified trainers won't easily close. Act now and you're building experience capital while the market is still underserved.